Personalized Therapies in Advanced Breast Cancer

May 16, 2014
Debu Tripathy, MD

Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, discusses new personalized therapies on the horizon for advanced breast cancer.

Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, discusses new personalized therapies on the horizon for advanced breast cancer.

Clinical Pearls:

  • Physicians have known for some time that there are molecular targets that are amenable to therapy
  • Now that the entire genome can be sequenced, physicians are understanding more about mutations in breast cancer
  • Upon sequencing the tumors of many patients with breast cancer, physicians are finding that no two tumors are the same
  • New mutations may be picked up after analyzing a patient’s tumor after treatment